1,426
Views
31
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Fatigue in COPD and the Impact of Respiratory Symptoms and Heart Disease—A Population-based Study

, , &
Pages 125-132 | Published online: 02 Apr 2013

Figures & data

Figure 1.  Flow chart of study population. *Subjects denying participation in 2007. **Subjects not able to attend to the yearly examination in 2007.

Figure 1.  Flow chart of study population. *Subjects denying participation in 2007. **Subjects not able to attend to the yearly examination in 2007.

Table 1.  Basic characteristics of the study population (n = 1350), p value for comparing COPD vs. non-COPD

Table 2.  FACIT-F scores in non-COPD, COPD and COPD with respiratory symptoms, by disease severity

Figure 2.  Box plots showing median and quartiles of FACIT-F score with a line depicting the clinical significant fatigue based on Minimally Important Difference, MID (defined as minus 3 units difference in median score from non-COPD). Non-COPD, COPD with respiratory symptoms (COPD-rs) stage I, II and III-IV.

Figure 2.  Box plots showing median and quartiles of FACIT-F score with a line depicting the clinical significant fatigue based on Minimally Important Difference, MID (defined as minus 3 units difference in median score from non-COPD). Non-COPD, COPD with respiratory symptoms (COPD-rs) stage I, II and III-IV.

Figure 3.  Median FACIT-F score in subjects without heart disease and with heart disease in the groups non-COPD, COPD and COPD stage I, II and III-IV. *Comparing subjects without heart disease and subject with heart disease.

Figure 3.  Median FACIT-F score in subjects without heart disease and with heart disease in the groups non-COPD, COPD and COPD stage I, II and III-IV. *Comparing subjects without heart disease and subject with heart disease.

Figure 4.  Multiple logistic regression analysis of risk factors for clinically significant fatigue, Minimally Important Difference, MID (defined as minus 3 units difference in median score from non-COPD) including the co-variates gender, age, COPD with respiratory symptoms (COPD-rs) by stage, heart disease and smoking habits, presented as odds ratio (OR) and 95% confidence intervals (CI). *Entered like a continuous variable (age OR 1.02, CI 1.01-1.03). **Reference = non-COPD. ***Reference = non-smoker.

Figure 4.  Multiple logistic regression analysis of risk factors for clinically significant fatigue, Minimally Important Difference, MID (defined as minus 3 units difference in median score from non-COPD) including the co-variates gender, age, COPD with respiratory symptoms (COPD-rs) by stage, heart disease and smoking habits, presented as odds ratio (OR) and 95% confidence intervals (CI). *Entered like a continuous variable (age OR 1.02, CI 1.01-1.03). **Reference = non-COPD. ***Reference = non-smoker.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.